Consolidated cash flow statements
(unaudited)
|
Six months ended 30 June |
|
---|---|---|
(thousands of €) |
2022 |
2021 |
Net loss of the period |
(32,338) |
(54,968) |
|
|
|
Adjustment for non-cash transactions |
6,567 |
50,310 |
Adjustment for items to disclose separately under operating cash flow |
3,529 |
2,518 |
Adjustment for items to disclose under investing and financing cash flows |
(416) |
(28,843) |
Change in working capital other than deferred income |
46,034 |
81,359 |
Cash used for other liabilities related to the acquisition of subsidiaries |
(7,765) |
- |
Decrease in deferred income |
(209,428) |
(248,610) |
Cash used in operations |
(193,818) |
(198,234) |
|
|
|
Interest paid |
(7,417) |
(5,862) |
Interest received |
757 |
1,237 |
Corporate taxes paid |
(3,262) |
(272) |
Net cash flows used in operating activities |
(203,740) |
(203,131) |
Purchase of property, plant and equipment |
(15,574) |
(19,414) |
Purchase of and expenditure in intangible fixed assets |
(1,783) |
(647) |
Purchase of current financial investments |
(1,842,495) |
(703,841) |
Interest received related to current financial investments |
210 |
8 |
Sale of current financial investments |
903,763 |
1,373,206 |
Cash in from disposals of subsidiaries, net of cash disposed of |
- |
28,696 |
Cash out from acquisition of subsidiaries, net of cash acquired |
(115,178) |
- |
Cash advances and loans to third parties |
(10,000) |
- |
Proceeds from sale of financial assets held at fair value through profit or loss |
- |
4,045 |
Net cash flows generated from/used in (-) investing activities |
(1,081,057) |
682,053 |
|
|
|
Payment of lease liabilities |
(3,980) |
(4,057) |
Proceeds from capital and share premium increases from exercise of subscription rights |
3,619 |
2,583 |
Net cash flows used in financing activities |
(361) |
(1,474) |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,285,158) |
477,448 |
|
|
|
Cash and cash equivalents at beginning of year |
2,233,368 |
2,143,071 |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,285,158) |
477,448 |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
24,586 |
22,121 |
|
|
|
Cash and cash equivalents at end of the period |
972,796 |
2,642,639 |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
30 June |
|
---|---|---|
(thousands of €) |
2022 |
2021 |
Current financial investments |
3,456,184 |
2,363,969 |
Cash and cash equivalents |
972,796 |
2,642,639 |
Current financial investments and cash and cash equivalents |
4,428,980 |
5,006,608 |
The accompanying notes form an integral part of these condensed consolidated financial statements.